Published in FEBS J on February 01, 2005
The collagen family. Cold Spring Harb Perspect Biol (2011) 2.10
Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron (2013) 1.78
The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol (2013) 1.73
Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther (2007) 1.60
Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci (2008) 1.49
Rapid interactome profiling by massive sequencing. Nucleic Acids Res (2010) 1.34
Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28
Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27
Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology (2009) 1.10
Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol (2010) 1.01
Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. PLoS One (2011) 0.98
Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. J Biol Chem (2011) 0.95
Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers. J Biol Chem (2009) 0.93
Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harb Perspect Med (2012) 0.92
Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA. J Biol Chem (2011) 0.92
Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. Int J Clin Exp Pathol (2008) 0.90
Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate. PLoS One (2011) 0.84
Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci (2006) 0.83
Altered gene expression in highly purified enterocytes from patients with active coeliac disease. BMC Genomics (2008) 0.83
Cell surface changes in the egg at fertilization. Mol Reprod Dev (2009) 0.80
Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic development. J Histochem Cytochem (2013) 0.80
Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation. Development (2009) 0.80
Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states. Cell Tissue Res (2014) 0.80
Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells. J Biol Chem (2009) 0.79
Integrative proteomic profiling of protein activity and interactions using protein arrays. Mol Cell Proteomics (2012) 0.78
Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin. PLoS One (2012) 0.78
Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family. ScientificWorldJournal (2014) 0.78
A non-reactive glutamine residue of alpha2-antiplasmin promotes interactions with the factor XIII active site region. J Thromb Haemost (2009) 0.77
Erythrocytic transglutaminase inhibition hemolysis at presentation of celiac disease. World J Gastroenterol (2010) 0.77
Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System. Adv Pharm Bull (2016) 0.77
Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. Anal Biochem (2014) 0.76
Detection of transglutaminase activity using click chemistry. Amino Acids (2011) 0.76
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. PLoS One (2013) 0.76
The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation. Oncotarget (2015) 0.76
Identification of transglutaminase reactive residues in human osteopontin and their role in polymerization. PLoS One (2014) 0.76
Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res (2013) 0.75
Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library. Cytotechnology (2010) 0.75
Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts. J Histochem Cytochem (2015) 0.75
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol (2003) 1.13
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. Gastroenterology (2007) 1.08
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J Biol Chem (2003) 0.94
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target. Curr Med Chem (2007) 0.78
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats. Protein Sci (2003) 0.77
Tissue transglutaminase and celiac disease. Prog Exp Tumor Res (2005) 0.77
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding. Int J Biochem Cell Biol (2003) 0.76
Chronic exposure to cadmium disrupts the adrenal gland activity of the newt Triturus carnifex (Amphibia, Urodela). Biomed Res Int (2013) 0.75
Seminal vesicle protein IV and its derived active peptides: a possible physiological role in seminal clotting. Semin Thromb Hemost (2007) 0.75